Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2009

Conditions
Asthma
Interventions
DRUG

Montelukast Placebo

"Seretide 100 Accuhaler 1 dose twice daily plus 1 tablet daily of placebo montelukast~Seretide 250 Accuhaler 1 dose twice daily plus 1 tablet daily of placebo montelukast~Seretide 500 Accuhaler 1 dose twice daily plus 1 tablet daily of placebo montelukast~Doses of montelukast or placebo: up to 6 years 4 mg once daily; 6-14 years 5 mg once daily; 15 years and above 10 mg once daily"

DRUG

Salmeterol, Montelukast

"Flixotide Accuhaler 50 micrograms per blister, 1 blister dose twice daily plus 1 tablet daily of montelukast~Flixotide Accuhaler 100 micrograms per blister; 1 blister dose twice daily plus 1 tablet daily of montelukast~Flixotide Accuhaler 250 micrograms per blister; 1 blister dose twice daily plus 1 tablet daily of montelukast~Flixotide Accuhaler 500 micrograms per blister; 1 blister dose twice daily plus 1 tablet daily of montelukast~Doses of montelukast or placebo: up to 6 years 4 mg once daily; 6-14 years 5 mg once daily; 15 years and above 10 mg once daily"

Trial Locations (1)

DD1 9SY

Maternal and Child Health Sciences, Ninewells Hospital and Medical School, Dundee

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Dundee

OTHER

NCT00655616 - Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics | Biotech Hunter | Biotech Hunter